Cargando…
Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens
BACKGROUND AND OBJECTIVES: Urinary tract infection is one of the most common bacterial infections causing high morbidity and mortality. The alarming rise of multidrug-resistant uropathogens worldwide forced the clinician to rethink the old drugs like Fosfomycin for its therapeutic management. Our ob...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723421/ https://www.ncbi.nlm.nih.gov/pubmed/36531821 http://dx.doi.org/10.18502/ijm.v14i5.10956 |
_version_ | 1784844172067340288 |
---|---|
author | Bir, Raunak Mohapatra, Sarita Kumar, Arvind Arif, Nazneen Tyagi, Sonu AK, Aswin Pius Gautam, Hitender Sood, Seema Das, Bimal Kumar Kapil, Arti |
author_facet | Bir, Raunak Mohapatra, Sarita Kumar, Arvind Arif, Nazneen Tyagi, Sonu AK, Aswin Pius Gautam, Hitender Sood, Seema Das, Bimal Kumar Kapil, Arti |
author_sort | Bir, Raunak |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: Urinary tract infection is one of the most common bacterial infections causing high morbidity and mortality. The alarming rise of multidrug-resistant uropathogens worldwide forced the clinician to rethink the old drugs like Fosfomycin for its therapeutic management. Our objective was to compare agar dilution, disc diffusion and E-test method for antimicrobial susceptibility testing of Fosfomycin against different drug-resistant uropathogens. MATERIALS AND METHODS: Consecutive 181 uropathogens were tested for Fosfomycin susceptibility using agar dilution, disc diffusion and E-test. Results were interpreted using Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints. Whole genome sequencing analysis was done on the 4 XDR/PDR Fosfomycin resistant Klebsiella pneumoniae isolates. RESULTS: Escherichia coli was found as the most common (62.4%) uropathogen followed by Klebsiella pneumoniae (21%). Considering agar dilution as the gold standard, 6.1% of isolates were resistant to Fosfomycin. Following CLSI breakpoints, the susceptibility of Escherichia coli, Klebsiella pneumoniae, other Enterobacterales and Pseudomonas aeruginosa were 92.9%, 92.1%, 100%, 100%; whereas using EUCAST breakpoints the susceptibility rates were 85.7%, 86.9%, 92.9%, and 100%, respectively. The essential agreement, categorical agreement, major error, and very major error for E-test/disc diffusion for all the organisms were 91.2%/Not Applicable, 95%/93.9%, 1.8%/4.7%, 9.1%/9.1%, respectively. Whole-genome sequencing showed mutation UhpT gene as well as the presence of plasmid-mediated fosA5 or fosA6 genes conferring Fosfomycin resistance. CONCLUSION: This result supports very low resistance of Enterobacterales against Fosfomycin; hence should be considered a valuable option to treat multidrug-resistant uropathogens. Disc diffusion was observed to be a convenient method for Fosfomycin susceptibility testing compared to agar dilution. |
format | Online Article Text |
id | pubmed-9723421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-97234212022-12-15 Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens Bir, Raunak Mohapatra, Sarita Kumar, Arvind Arif, Nazneen Tyagi, Sonu AK, Aswin Pius Gautam, Hitender Sood, Seema Das, Bimal Kumar Kapil, Arti Iran J Microbiol Original Article BACKGROUND AND OBJECTIVES: Urinary tract infection is one of the most common bacterial infections causing high morbidity and mortality. The alarming rise of multidrug-resistant uropathogens worldwide forced the clinician to rethink the old drugs like Fosfomycin for its therapeutic management. Our objective was to compare agar dilution, disc diffusion and E-test method for antimicrobial susceptibility testing of Fosfomycin against different drug-resistant uropathogens. MATERIALS AND METHODS: Consecutive 181 uropathogens were tested for Fosfomycin susceptibility using agar dilution, disc diffusion and E-test. Results were interpreted using Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints. Whole genome sequencing analysis was done on the 4 XDR/PDR Fosfomycin resistant Klebsiella pneumoniae isolates. RESULTS: Escherichia coli was found as the most common (62.4%) uropathogen followed by Klebsiella pneumoniae (21%). Considering agar dilution as the gold standard, 6.1% of isolates were resistant to Fosfomycin. Following CLSI breakpoints, the susceptibility of Escherichia coli, Klebsiella pneumoniae, other Enterobacterales and Pseudomonas aeruginosa were 92.9%, 92.1%, 100%, 100%; whereas using EUCAST breakpoints the susceptibility rates were 85.7%, 86.9%, 92.9%, and 100%, respectively. The essential agreement, categorical agreement, major error, and very major error for E-test/disc diffusion for all the organisms were 91.2%/Not Applicable, 95%/93.9%, 1.8%/4.7%, 9.1%/9.1%, respectively. Whole-genome sequencing showed mutation UhpT gene as well as the presence of plasmid-mediated fosA5 or fosA6 genes conferring Fosfomycin resistance. CONCLUSION: This result supports very low resistance of Enterobacterales against Fosfomycin; hence should be considered a valuable option to treat multidrug-resistant uropathogens. Disc diffusion was observed to be a convenient method for Fosfomycin susceptibility testing compared to agar dilution. Tehran University of Medical Sciences 2022-10 /pmc/articles/PMC9723421/ /pubmed/36531821 http://dx.doi.org/10.18502/ijm.v14i5.10956 Text en Copyright © 2022 The Authors. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
spellingShingle | Original Article Bir, Raunak Mohapatra, Sarita Kumar, Arvind Arif, Nazneen Tyagi, Sonu AK, Aswin Pius Gautam, Hitender Sood, Seema Das, Bimal Kumar Kapil, Arti Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens |
title | Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens |
title_full | Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens |
title_fullStr | Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens |
title_full_unstemmed | Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens |
title_short | Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens |
title_sort | genomic analysis of fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723421/ https://www.ncbi.nlm.nih.gov/pubmed/36531821 http://dx.doi.org/10.18502/ijm.v14i5.10956 |
work_keys_str_mv | AT birraunak genomicanalysisoffosfomycinresistanceinmultidrugresistanturopathogensandcomparisonofinvitrosusceptibilitymethodsuropathogens AT mohapatrasarita genomicanalysisoffosfomycinresistanceinmultidrugresistanturopathogensandcomparisonofinvitrosusceptibilitymethodsuropathogens AT kumararvind genomicanalysisoffosfomycinresistanceinmultidrugresistanturopathogensandcomparisonofinvitrosusceptibilitymethodsuropathogens AT arifnazneen genomicanalysisoffosfomycinresistanceinmultidrugresistanturopathogensandcomparisonofinvitrosusceptibilitymethodsuropathogens AT tyagisonu genomicanalysisoffosfomycinresistanceinmultidrugresistanturopathogensandcomparisonofinvitrosusceptibilitymethodsuropathogens AT akaswinpius genomicanalysisoffosfomycinresistanceinmultidrugresistanturopathogensandcomparisonofinvitrosusceptibilitymethodsuropathogens AT gautamhitender genomicanalysisoffosfomycinresistanceinmultidrugresistanturopathogensandcomparisonofinvitrosusceptibilitymethodsuropathogens AT soodseema genomicanalysisoffosfomycinresistanceinmultidrugresistanturopathogensandcomparisonofinvitrosusceptibilitymethodsuropathogens AT dasbimalkumar genomicanalysisoffosfomycinresistanceinmultidrugresistanturopathogensandcomparisonofinvitrosusceptibilitymethodsuropathogens AT kapilarti genomicanalysisoffosfomycinresistanceinmultidrugresistanturopathogensandcomparisonofinvitrosusceptibilitymethodsuropathogens |